{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:03:42Z","timestamp":1767891822938,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010977","name":"Cognitive Neuroscience Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","strokejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.033","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T06:26:05Z","timestamp":1409898365000},"page":"2350-2361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Strong Reduction of Low-Density Lipoprotein Receptor\/Apolipoprotein E Expressions by Telmisartan in Cerebral Cortex and Hippocampus of Stroke Resistant Spontaneously Hypertensive Rats"],"prefix":"10.1016","volume":"23","author":[{"given":"Yun","family":"Zhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syoichiro","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Omote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Hishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cger.2009.12.001","article-title":"Dementia risk prediction: are we there yet?","volume":"26","author":"Kamat","year":"2010","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/gerona\/glq079","article-title":"Increased fructose intake as a risk factor for dementia","volume":"65","author":"Stephan","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0047-6374(01)00426-2","article-title":"Ageing of the brain","volume":"123","author":"Anderton","year":"2002","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib4","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","article-title":"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis","volume":"21","author":"Pratico","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijdevneu.2004.07.006","article-title":"Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology","volume":"22","author":"Apelt","year":"2004","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib6","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.freeradbiomed.2008.03.012","article-title":"Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease","volume":"44","author":"Resende","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0169-328X(02)00647-2","article-title":"Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques","volume":"110","author":"Burns","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the\u00a0proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer\u2019s disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2217\/bmm.09.83","article-title":"Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease","volume":"4","author":"Fagan","year":"2010","journal-title":"Biomark Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","article-title":"Biomarkers for Alzheimer\u2019s disease: academic, industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/VHRM.S11816","article-title":"Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination","volume":"6","author":"Cagnoni","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nurt.2008.05.003","article-title":"PPAR gamma agonists as therapeutics for the treatment of Alzheimer\u2019s disease","volume":"5","author":"Landreth","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0300-483X(00)00312-7","article-title":"Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats","volume":"153","author":"Kimura","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.expneurol.2007.11.028","article-title":"Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure","volume":"210","author":"Kumai","year":"2008","journal-title":"Experimental neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib17","first-page":"123","article-title":"Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats","volume":"2","author":"Wienen","year":"2001","journal-title":"JRAAS"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib18","unstructured":"Kurata T, Lukic V, Kozuki M, et\u00a0al. Telmisartan reduces progressive Alzheimer pathology with inflammatory responses in aged SHR-SR rat. J Stroke Cerebrovasc Dis (under revision)."},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.STR.7.2.120","article-title":"Hypertension as an important factor for cerebrovascular atherogenesis in rats","volume":"7","author":"Yamori","year":"1976","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0021-9150(77)90171-X","article-title":"Lipid metabolism in spontaneously hypertensive rats (SHR)","volume":"28","author":"Iritani","year":"1977","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00210-006-0069-y","article-title":"Metabolic effects of telmisartan in spontaneously hypertensive rats","volume":"373","author":"Li","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molbrainres.2004.10.037","article-title":"Up-regulation of low-density lipoprotein receptor expression in the ischemic core and the peri-ischemic area after transient MCA occlusion in rats","volume":"134","author":"Kamada","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3940(99)00623-0","article-title":"Age-related change of antioxidant capacities in the cerebral cortex and hippocampus of stroke-prone spontaneously hypertensive rats","volume":"273","author":"Kimoto-Kinoshita","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib24","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.052","article-title":"Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats","volume":"23","author":"Fukui","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1161\/01.STR.29.9.1972","article-title":"Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats","volume":"29","author":"Li","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib26","doi-asserted-by":"crossref","first-page":"13319","DOI":"10.1523\/JNEUROSCI.1324-10.2010","article-title":"POSH is an intracellular signal transducer for the axon outgrowth inhibitor Nogo66","volume":"30","author":"Dickson","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(91)90510-6","article-title":"Inhibition of MAP2 expression affects both morphological and cell division phenotypes of neuronal differentiation","volume":"64","author":"Dinsmore","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib28","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1073\/pnas.78.5.3010","article-title":"High molecular weight microtubule-associated proteins are preferentially associated with dendritic microtubules in brain","volume":"78","author":"Matus","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1083\/jcb.200110134","article-title":"MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction","volume":"158","author":"Harada","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0306-4522(03)00094-0","article-title":"Deletion of the N-terminus of murine MAP2 by gene targeting disrupts hippocampal ca1 neuron architecture and alters contextual memory","volume":"119","author":"Khuchua","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1083\/jcb.200106025","article-title":"Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization","volume":"155","author":"Teng","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneur.56.8.991","article-title":"Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use","volume":"56","author":"Guo","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib33","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/archinte.162.18.2090","article-title":"Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans","volume":"162","author":"Murray","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1592\/phco.28.3.366","article-title":"Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment","volume":"28","author":"Poon","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2009.01.013","article-title":"Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy","volume":"209","author":"Zilka","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","article-title":"ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in\u00a0vivo","volume":"41","author":"DeMattos","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib37","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1073\/pnas.0409072102","article-title":"Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer\u2019s disease","volume":"102","author":"Dodart","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K","article-title":"Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury","volume":"60","author":"Genis","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib39","doi-asserted-by":"crossref","first-page":"8832","DOI":"10.1073\/pnas.151253098","article-title":"Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice","volume":"98","author":"Bi","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib40","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.1434398100","article-title":"Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer\u2019s disease-like neurodegeneration and behavioral deficits in transgenic mice","volume":"100","author":"Harris","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2014.05.033_bib41","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J Neurosci"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305714002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305714002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:38:20Z","timestamp":1760942300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305714002791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1052305714002791"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.05.033","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strong Reduction of Low-Density Lipoprotein Receptor\/Apolipoprotein E Expressions by Telmisartan in Cerebral Cortex and Hippocampus of Stroke Resistant Spontaneously Hypertensive Rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Stroke and Cerebrovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2014.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}